Handelsbanken Fonder’s Immunomedics Inc IMMU Stock Holding History

Handelsbanken Fonder’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-36,918	Closed	-$3.14M	–	1567
2020 Q3	$3.14M	Buy	36,918 +2,900	+9%	+$147K	0.02%	454
2020 Q2	$1.21M	Buy	+34,018	New	+$995K	0.01%	635

Handelsbanken Fonder's IMMU Position: Q4 2020 in Review

Handelsbanken Fonder sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 36,918 shares — an estimated $3.14M sold.

Handelsbanken Fonder first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $3.14M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Handelsbanken Fonder reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Handelsbanken Fonder sold 36,918 Immunomedics Inc shares in Q4 2020, an estimated $3.14M.
Handelsbanken Fonder first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
Handelsbanken Fonder's Immunomedics Inc position peaked at $3.14M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Handelsbanken Fonder's 13F filing for Q4 2020, filed 11 Feb 2021.